Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Ambra PACS

K-Number: K231360 · 2023-06-07

Decision Date2023-06-07
Product CodeLLZ
Advisory CommitteeRA
DecisionSubstantially Equivalent

Device Summary

Ambra PACS is the device name listed in this FDA 510(k) record. The listed applicant is Dicom Grid Dba Ambra Health. It received FDA 510(k) clearance on 2023-06-07 under 510(k) number K231360. The device is classified under product code LLZ. It was reviewed by the RA advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Ambra PACS?

Ambra PACS is a medical device that received FDA 510(k) clearance on 2023-06-07. The listed applicant is Dicom Grid Dba Ambra Health. The 510(k) number is K231360.

When did Ambra PACS receive FDA 510(k) clearance?

Ambra PACS received FDA 510(k) clearance on 2023-06-07, under 510(k) number K231360.

Who is the listed applicant for Ambra PACS?

The FDA 510(k) record lists Dicom Grid Dba Ambra Health as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for Ambra PACS?

The FDA product code for Ambra PACS is LLZ.

Related Devices (Code: LLZ)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.